Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Pradaxa (dabigatran etexilate) – Oral Direct Thrombin Inhibitor

Drug (brand/generic)

Pradaxa (dabigatran etexilate)

Company/Licensee

Boehringer Ingelheim

Therapy Class

Anticoagulant

Product Description

Direct thrombin inhibitor

Current Indication

Primary prevention and treatment of VTE following orthopaedic surgery

Market Sector

Cardiovascular

Development Status

Approved in Europe, the US and Japan
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM

Go Top